Paying users zone. Data is hidden behind hidden.

  • Get 1-month access to Boston Scientific Corp. for $15.99, or

  • get full access to the entire website for at least 3 months from $49.99.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey
Unlock

This is a one-time payment. There is no automatic renewal.

Microsoft Excel LibreOffice Calc

Boston Scientific Corp. (NYSE:BSX)

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity

Beginner level

Boston Scientific Corp., common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Current debt obligations
Accounts payable
Legal reserves
Payroll and related liabilities
Accrued contingent consideration
Rebates
Other
Accrued expenses
Deferred revenue
Licensing arrangements
Taxes payable
Other
Other current liabilities
Current liabilities
Long-term debt
Deferred tax liabilities
Accrued income taxes
Legal reserves
Accrued contingent consideration
Licensing arrangements
Long-term operating lease liabilities
Other
Other long-term liabilities
Long-term liabilities
Total liabilities
Preferred stock, $0.01 par value, none issued and outstanding
Common stock, $0.01 par value
Treasury stock, at cost
Additional paid-in capital
Accumulated deficit
Foreign currency translation adjustment
Unrealized gain (loss) on derivative financial instruments
Unrealized gain (loss) on available-for-sale securities
Unrealized costs associated with defined benefit pensions and other items
Accumulated other comprehensive income (loss), net of tax
Stockholders’ equity
Total liabilities and stockholders’ equity

Based on: 10-K (filing date: 2020-02-25), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-24).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Boston Scientific Corp.’s current liabilities as a percentage of total liabilities and stockholders’ equity decreased from 2017 to 2018 and from 2018 to 2019.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Boston Scientific Corp.’s long-term liabilities as a percentage of total liabilities and stockholders’ equity decreased from 2017 to 2018 but then increased from 2018 to 2019 exceeding 2017 level.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Boston Scientific Corp.’s total liabilities as a percentage of total liabilities and stockholders’ equity decreased from 2017 to 2018 and from 2018 to 2019.
Stockholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Boston Scientific Corp.’s stockholders’ equity as a percentage of total liabilities and stockholders’ equity increased from 2017 to 2018 and from 2018 to 2019.